List of bibliographic references
Number of relevant bibliographic references: 5.
List of associated KwdEn.i
Nombre de documents | Descripteur |
4 | Humans |
4 | Parkinson Disease (drug therapy) |
3 | Aged |
3 | Antiparkinson Agents (adverse effects) |
3 | Antiparkinson Agents (therapeutic use) |
3 | Confidence Intervals |
3 | Double-Blind Method |
3 | Female |
3 | Longitudinal Studies |
3 | Male |
3 | Middle Aged |
3 | Ropinirole |
3 | Severity of Illness Index |
2 | Adult |
2 | Analysis of Variance |
2 | Disease Progression |
2 | Dopamine Agonists (therapeutic use) |
2 | Dopamine agonist |
2 | Double‐blind, controlled study |
2 | Drug Therapy, Combination |
2 | Early Parkinson's disease |
2 | Indoles (adverse effects) |
2 | Indoles (therapeutic use) |
2 | Levodopa |
2 | Levodopa (adverse effects) |
2 | Nervous system diseases |
2 | Odds Ratio |
2 | Parkinson disease |
2 | Parkinson's disease |
2 | Regression Analysis |
2 | Treatment Outcome |
1 | Bromocriptine |
1 | Bromocriptine (adverse effects) |
1 | Bromocriptine (therapeutic use) |
1 | Catechols (therapeutic use) |
1 | Dopamine Agonists (adverse effects) |
1 | Dyskinesia |
1 | Dyskinesia, Drug-Induced (etiology) |
1 | Dyskinesia, Drug-Induced (mortality) |
1 | Freezing |
1 | Freezing Reaction, Cataleptic (drug effects) |
1 | Freezing Reaction, Cataleptic (physiology) |
1 | Gait Disorders, Neurologic (chemically induced) |
1 | Gait Disorders, Neurologic (diagnosis) |
1 | Gait Disorders, Neurologic (drug therapy) |
1 | Gait Disorders, Neurologic (physiopathology) |
1 | Human |
1 | Indans (therapeutic use) |
1 | Levodopa (therapeutic use) |
1 | Neuroprotective Agents (therapeutic use) |
1 | Nitriles (therapeutic use) |
1 | Parkinson Disease (epidemiology) |
1 | Parkinson Disease (mortality) |
1 | Predictive Value of Tests |
1 | Principal Component Analysis |
1 | Proportional Hazards Models |
1 | Psychiatric Status Rating Scales |
1 | Questionnaire |
1 | Questionnaires |
1 | Rasagiline |
1 | Reproducibility of Results |
1 | Risk Factors |
1 | Selegiline |
1 | Selegiline (therapeutic use) |
1 | Statistics as Topic |
1 | Survival Analysis |
1 | Validation |
1 | dyskinesia |
1 | freezing of gait |
1 | levodopa |
1 | rasagiline |
1 | ropinirole |
1 | validation |
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/France/Analysis
HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/Author.i -k "David J. Brooks"
HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/Author.i \
-Sk "David J. Brooks" \
| HfdSelect -Kh $EXPLOR_AREA/Data/France/Analysis/biblio.hfd
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= MovDisordV3
|flux= France
|étape= Analysis
|type= indexItem
|index= Author.i
|clé= David J. Brooks
}}
| This area was generated with Dilib version V0.6.23. Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024 | ![](Common/icons/LogoDilib.gif) |